EREMY LACK is a lawyer and ADR neutral admitted to the bars of England & Wales (1989), New York, USA (1990) and Geneva, Switzerland (2003, as a foreign lawyer). He specializes in international commercial, technology, life sciences and intellectual property matters, and complex disputes. In addition to his own law firm (LAWTECH.CH), Jeremy is a Door Tenant with QUADRANT CHAMBERS (GB), counsel to HELVETICA AVOCATS SARL (CH), and serves as an Ombudsperson for DRUGS FOR NEGLECTED DISEASES INITIATIVE (CH). Jeremy has served as General Counsel to several companies, including SONARSOURCE SA (CH) and MINDMAZE (CH) and as International Counsel to BECTON DICKINSON, INC., and has served on the boards of directors of several companies and organizations. He is the founder and executive director of InnovADR Ltd., an ADR fund that designs and invests in mixed mode cases (including mediation, conciliation, arbitration and combinations thereof) on a “no settlement, no fee” basis and is also a co-founder of Neuroawareness Ltd. Jeremy is a certified IMI mediator and mediation advocate and is a listed ADR panelist with many international dispute resolution centers. He has been ranked by WHO’S WHO LEGAL as a national leader since 2010, as one of the ten most highly regarded mediators in 2011, as one of the most highly regarded firms in 2012 and 2013, and as a Global Elite Thought Leader from 2019-2024. He is active in many law and ADR organizations. He holds an MA (Oxon) degree in law and physiological sciences from Lincoln College, Oxford University. He works in English, French and Spanish, and has Swiss, British, US and Israeli citizenships. He lives in Geneva, Switzerland, from where he often co-mediates working with other ADR neutrals, working online. Jeremy designs and implements bespoke international commercial dispute resolution processes in a wide range of fields and industries that are tailored to the parties’ procedural needs in each case, based on 7 key drivers: (1) costs, (2) time, (3) relationships, (4) control of process, (5) control of outcome, (6) confidentiality and (7) enforceability. For more information, please see: www.lawtech.ch and www.innovadr.com.